We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8031:TSEMitsui & Co.,Ltd Analysis

Data as of 2026-05-23 - not real-time

¥5,580.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Mitsui & Co. trades around ¥5,580, delivering a trailing P/E of roughly 19, well below the conglomerate industry average of about 30, which signals a relative value advantage. The stock’s dividend yield sits at 2.5% with a payout ratio under 40%, suggesting the payout is comfortably supported by operating cash flow despite a negative free cash flow figure. Technicals are mixed: RSI hovers near 40, the MACD remains bearish and volume is trending down, while price is perched just above a key support level around ¥5,458 and below the next resistance near ¥6,225. A recent long‑term cobalt offtake agreement positions Mitsui to capture growth in critical minerals, offsetting a modest –1.1% revenue contraction and low margin profile.
Overall, the combination of a solid dividend, attractive valuation relative to peers, and strategic exposure to clean‑energy commodities points to a “hold‑with‑upside” stance in the near term, while the longer‑term narrative remains anchored to global commodity demand and the company’s diversified business model.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume suggest limited upside
  • Price near recent support level provides downside cushion
  • Dividend yield offers modest income while waiting for catalyst

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Cobalt offtake agreement expands exposure to critical minerals
  • Valuation advantage versus industry peers (P/E ~19 vs 30)
  • Stable dividend payout supported by operating cash flow

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Diversified global commodity portfolio benefits from energy transition
  • Low beta (≈0.36) indicates limited volatility over long horizons
  • Sustainable dividend and solid balance sheet underpin shareholder returns

Key Metrics & Analysis

Financial Health

Revenue Growth-1.10%
Profit Margin5.96%
P/E Ratio19.2
ROE10.30%
ROA1.60%
Debt/Equity63.29
P/B Ratio1.8
Op. Cash Flow¥952.9B
Free Cash Flow¥-484675485696
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI40.3
Support¥5,458.00
Resistance¥6,225.00
MA 20¥5,794.80
MA 50¥6,004.10
MA 200¥4,662.42
MACDBearish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value¥1,395.48
Target Price¥6,491.54
Upside/Downside16.34%
GradeFair
TypeValue
Dividend Yield2.51%

Risk Assessment

Beta0.36
Volatility32.86%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.